Table of contents
At a glance
How do you validate Haufe X360 for a GxP-relevant material workflow?
Define the use across the ERP core, process manufacturing, QMS add-on and interfaces. Trace how a quality decision governs material use and whether the actual posting follows that decision. Record the tenant build, module versions, roles and changes. Test alternative materials, delayed status updates and repeated confirmations. An integrated interface or the underlying Acumatica platform does not demonstrate that the installed combination works.
- The Kern-ERP, process manufacturing, and the implemented QMS solution require a common, explicitly documented system boundary.
- Inventory calculation, technical selection, and professionally justified substitution are distinct concepts.
- A complete audit trail links quality decisions, actual consumption, and unambiguously assigned inventory records.
- The roadmap, development environment and production tenant describe different states. Check each separately.
Which specific Haufe-X360 combination is actually implemented
Haufe X360 is offered as a cloud-based ERP solution for SMEs. The product page lists Acumatica as a technology partner. However, this does not imply that any Acumatica edition, module, or documentation applies unchanged to your Haufe X360 installation. Always start with the actually agreed-upon scope of services and the active tenant, i.e., your specific application environment.
For a quality-related material process, several components may interact: ERP core, manufacturing process, quality solution, interfaces, and customer customizations. The Quality Management Suite presented in the Haufe catalog is developed by eWorkplace Apps LLC. Verify that this exact solution is in use, which modules are licensed, and which versions are operated together. A catalog page does not constitute confirmation of the order scope.
The following regulatory considerations pertain to a specific human medicinal product GMP process. Annex 11 addresses computerised systems on a risk-based approach. A commercial use, a food business, or a medical device process does not automatically inherit the same regulatory framework under the same ERP system.
Base formulation, alternative raw materials, and customer decision separation
The public page for process manufacturing outlines formulations, unit conversion, revisions, and release workflows. It also lists alternative raw materials without altering the base recipe. This raises a clear validation question: Where is it demonstrably documented which material was actually authorized and used for each order, when the overall recipe master batch remains unchanged?
Distinguish an alternative raw material from a different batch of the same raw material. Both situations may require technical decisions, but for different reasons. For a different substance, specifications and suitability for formulation may be affected; for a substitute batch, a new quality assessment result may be decisive. The actual testing scope depends on the process and is not determined by the technical availability of alternatives.
Before inspection, define the conditions under which a substitution is permitted, who has authority to approve such substitutions, and how the link to the order and dispensing remains intact. Subsequently, assess the actual execution pathway. The fact that an alternative master data option is authorized does not automatically imply that any existing batch of that alternative may be used in the current order.
Make the detection limit between ERP, process manufacturing, and QMS visible
An integrated solution can seamlessly consolidate information. Nevertheless, it should remain evident which component generates, modifies, and evaluates any given information. The Quality Management Suite is described with testing, deviations, CAPA, and other quality functions. Which of these actually controls your material process depends on the specific implementation.
Use the following working matrix as a starting point. Complete system managers, suitable documentation and detection locations. The crucial factor is the transition from the quality information evaluated to the effective material decision. A correct test result is not sufficient if the running process uses an outdated status.
| Component | Publicly described scope | Evidence in your combination |
|---|---|---|
| ERP-Core | Business, procurement, and inventory processes | Batch, quantity, and booking are part of the correct order and material. |
| Process manufacturing | Formulations, revisions, units, and alternative raw materials | The permitted substitution and the recipe or order version actually executed remain traceable. |
| eWorkplace-Apps-QMS | Inspections, deviations, CAPA and quality certifications | The evaluated finding and responsible decision reach the actual intended use. |
| Interface or customization | Integration options; specific implementation tailored to project requirements | Identity, sequence, and handling of repeated or erroneous messages are verified. |
| Cloud Tenant and Test Environment | Cloud deployment; separate developer tools | The build, modules, roles and active endpoints are representative of the scenario being tested. |
Deriving a controlled use from a quality finding
Define the meaning in the process of each used state. An open inspection, a completed inspection, and a permitted use for a specific purpose are not necessarily equivalent. Avoid requirements such as "The QMS controls release" until it is clear which decision is intended and its impact on the ERP system.
Assess the authorized pathway and appropriate countermeasures: A result remains open, a decision is being deferred, or transfer to the manufacturing process is delayed. Prior to action, define which actions are permitted and what information the responsible personnel requires. Whether implementation is technically blocked, actively alerts, or prescribes an alternative controlled route must be evaluated against the actual process.
For roles, the same level of accuracy applies. Anyone who records a finding does not necessarily need automatic authority to approve substitutions. Conversely, a universal QA signature for every material movement cannot be derived. Document authorizations, required qualifications, and decision reference points should be established such that a technical status change does not unilaterally replace a professional judgment.
Expected results for a replacement batch and unambiguous consumption
The following example serves as a work aid only and does not represent a completed Haufe-X360 test. An order requires 25 kg of a raw material. Batch A has a stock of 40 kg, but its quality assessment remains unclear for intended use. Batch B contains 30 kg; its quality evaluation is appropriate for the intended purpose, although substitution in the order is still pending. Both batches are recorded in kilograms.
For each independent fault scenario, the initial state is recreated. In the example, there are no losses, additional movements, or unit conversions. The expected response is a predefined process requirement. The matrix neither asserts a native protection mechanism against duplicate messages nor acknowledges the validity of negative balances.
| Incident and Situation Overview | Invoice or failure image | Proof and assurance of suitability |
|---|---|---|
| A: 40 kg; Order: 25 kg; Quality result open | 40 − 25 = 15 kg, so the quantity would permit the transaction | Availability of quantities is not permitted; first clarify the intended quality decision. |
| B: 30 kg; appropriate quality assessment; replacement decision pending | 30 − 25 = 5 kg would be feasible in terms of quantity. | No sole reliance on technical selection; substitution decisions are order-based. |
| B is authorized for this task; consumption per batch: 25 kg | 30 − 25 = 5 kg | Decision, actual B-Batch, order, and exactly this consumption booking are linked. |
| Permitted partial consumption: initially 10 kg, then 15 kg | 30 − 10 = 20 kg; 20 − 15 = 5 kg; 10 + 15 = 25 kg | Both sub-processes are distinguishable; the sum and the balance are correct. |
| Error: the same 25-kg notification is being resent | A second booking would calculate to 30 − 25 − 25 = −20 kg | No undetected secondary processing; demonstrate actual detection and corrective action. |
| Error: B recorded in ERP, physical A removed | The B-balance could still show 5 kg. | Detect identity deviation; a matching inventory quantity does not prove correct material usage. |
| Error: Older status message overrides new decision | Mass balance unchanged, decision status inconsistent | Detect and treat the aged condition in a regulated manner; do not make business decisions only after arrival time. |
Review interface errors and order reconstruction jointly.
The platform describes integration options via APIs. Specific endpoints, confirmations, retry rules, and technical error handling within your solution have not yet been validated. Request a description of the actual integration interfaces in use. Document how order, material, batch, unit, and decision are identified, and specify which information confirms successful processing.
Do not only verify the resending of a message, but also check for interruptions between processing and feedback. The sender may then detect an error, even though the recipient has already been booked. The appropriate handling must align with real-time integration. Both manual correction and automated retry require a well-defined, traceable procedure.
For a completed order, the used batch, relevant quality decisions, and actual consumption should be reconstructible together. Identify the required electronic records and change information for this purpose. A PDF can provide a readable output, but alone does not prove that all required data relationships are preserved. The audit trail scope and review should be aligned with the risk assessment and the intended decision purpose.
Separate productive build, roadmap, and test configuration
On 6 October 2026, the public Roadmap 2026R1 identifies the upcoming Major Release. This announcement does not indicate that your tenant has already adopted this version. Document the actual build, module status, and activated features. Specific update windows, deferment options, and conditions must be derived from the relevant customer information; rules from other cloud ERP products do not constitute a substitute.
The official developer documentation describes the installation of selected builds and the creation of applications using demo data or tenant templates. Even the empty template described there includes predefined roles and web service endpoints. Therefore, a newly established test system is not inherently neutral or production-equivalent solely due to its name.
Purposefully compare attributes that impact your validation: modules, customizations, permissions, units, relevant master data, and interfaces. Use appropriate, controlled test data. The documented on-premises developer environment also does not represent a general commercial on-premises offering. Productive cloud operations and local development tools have distinct responsibilities and validation boundaries.
Evaluate supplier contributions and ongoing changes
With a combination of ERP core, add-on solutions, and implementation partner, supplier contributions should be assigned based on their actual scope of coverage. A targeted functional review can provide partial support for meeting your requirements. A general platform or security description does not automatically address how your material substitution is configured. Specifically request the missing documentation.
Evaluate the impact of changes regarding the associated decisions or supporting evidence. A new QMS field, modified role permissions, interface adjustment, or a new processing pathway may alter the intended use case. Align repeat validation activities accordingly and document the rationale. A general full revalidation following every cloud update is equally unhelpful, and the assumption that cloud changes are broadly covered is not justified.
You must also manage disruptions, recovery, and retention of required ERP and quality data. Cloud operation does not eliminate these responsibilities, but it can distribute their execution across multiple stakeholders. Key considerations are agreed responsibilities and appropriate evidence of actual data usage; the mere assumption of indefinite, universal data retention is not derived.
Contribution and effort required for a manageable project
First, prepare a representative material process: order, recipe, acceptable alternatives, inspection plan, responsibilities, and booking pathway. Designate a technical point of contact for material selection and technical points of contact for core systems, QMS, and integration. This preparation enables targeted inquiries to suppliers and prevents a general functional demonstration from being misinterpreted as project validation evidence.
The effort depends particularly on the number of module boundaries, customer customizations, and disparate data pathways. Additionally, the quality of existing documentation, historical batch data, and the availability of an appropriate test environment must be considered. Five nearly identical standard processes may require less clarification than a single exception pathway with unclear ownership. Therefore, a reliable estimation necessitates a well-defined scope.
Prioritize first the transfers at which an incorrect status, a mix-up, or double processing could influence a quality decision. Thereafter, align existing supplier tests purposefully and define additional checks. This establishes a clear and traceable work foundation, without predefining project timelines, costs, or expected outcomes.
Decision-making checklist for continuous usage evaluation
Evaluate the following points based on available evidence for your specific combination. This list is an internal work aid and does not constitute a legally mandated document set. Open issues require a clear assessment of their impact. An unclear link between quality decisions and actual usage should not be obscured by a formally completed module test.
- Tenant-Build, Module, Add-on Solutions, Customizations, and Responsible Suppliers are recorded.
- Alternative raw materials and substitute batches are technically differentiated; permitted substitutions are defined.
- Quality states, decision authorities, and their impact on material usage are described.
- A representative order links decision, actual batch, and booking in a traceable manner.
- Partial distribution, repeated notifications, misidentification, and outdated status are risk-basedly evaluated.
- The test environment includes the relevant roles, modules, and interfaces required for these assessments.
- Required records, change information, and review responsibilities are defined.
- Cloud modifications, disruptions, storage, and recovery have defined responsibilities.
Project experience and collaboration
Trace the material decision through to posting
For a Haufe X360 configuration, we trace a material decision through to the actual posting with your process team, implementation partner and IT. We identify the roles of the ERP core, process manufacturing, QMS extension and interface. A limited module extension may need targeted transfer tests. If status rules or alternative material paths remain unresolved, we establish the process first. We can then test delayed and repeated messages as well as a successful normal run.
FAQ on Haufe X360 and quality decisions
Is Haufe X360 automatically suitable for a GMP process?
The suitability arises from the specific application and its supporting evidence. Cloud-based ERP, technology partnership, and integrated quality functions are insufficient on their own. First, define which human medicinal product GMP decision is supported. Then, assess the actual modules, configurations, and transitions. For other industries or purely commercial uses, a different scope of applicability may be relevant.
Is the Quality Management Suite included in the base system?
The public Haufe Catalog describes the Quality Management Suite from eWorkplace Apps LLC as an integrated solution. This does not confirm that it is included in every base license or activated in every tenant. Please verify your scope of services, vendor, module status, and functionalities in use. Do not assume that complete QMS, audit, or signature capabilities are provided solely based on the name of the solution.
Sources: [3]
What does the use of alternative raw materials mean without changing the basic formula?
It is intended to use an alternative raw material on behalf of a specific order, without altering the core recipe. This flexible material substitution is managed from the manufacturing process side. However, for your validation evidence, it remains essential to clearly define which material was specifically authorized and actually used for the particular order. Establish clear conditions and decision authority for such substitutions. The unchanged base recipe does not substitute for the order-specific decision and execution justification. Simply providing a list of available options does not constitute professional justification for the use of any alternative.
Why do we differentiate a substitute batch from an alternative raw material?
A substitute batch may consist of the same material yet have a different quality assessment. An alternative raw material may also bring additional technical properties and formulation prerequisites. Therefore, evaluate what is actually being substituted and which decision depends on that. The software function for material selection does not definitively establish the technical evaluation scope. In the example of this article, only a substitute batch of the same raw material is intentionally considered.
Does Haufe X360 automatically prevent use of a batch that is not authorised?
A general blocking effect is not substantiated by the public functional pages. Verify your specific configuration involving quality status, roles, manufacturing route, and booking. Define in advance the desired effect and test appropriate countermeasures. Whether a technical block, a warning, or another controlled process is appropriate must be evaluated based on the intended use and its risk profile.
How do we verify a double consumption feedback?
Use a defined starting inventory and a uniquely identifiable process. In the example provided in this article, 30 kg minus one instance of 25 kg results in a remaining balance of 5 kg. Reiterate the same message and investigate the actual handling. An undetected second booking would constitute a different circumstance than an authorized second partial consumption. This does not assert any native protection function of the product.
Can we use the developer environment directly as a validation system?
Only to the extent that their characteristics are suitable for the intended validations. The documentation outlines selectable builds and templates; even an empty template includes standard roles and endpoints. Therefore, compare the relevant modules, customizations, permissions, and data pathways against your target configuration. Document any deviations and their implications. The local installation of a developer tool does not constitute an equivalent production operating environment.
Which Haufe X360 release is current?
For your project, the actually active Tenant Build, including relevant module versions, is relevant. The roadmap reviewed on 6 October 2026 identifies 2026R1 as the upcoming Major Release and provides no evidence of a previously completed rollout. Obtain the release information applicable to your Tenant. Plan evaluations based on the actually implemented changes and agreed conditions, not on a general roadmap announcement.
Must every quality decision be electronically signed off by QA?
Such a general directive cannot be derived from Annex 11. Key considerations are the established decision-making process, the specific authorization required, and the necessary documentation. A technical transition is not automatically an appropriate signature. If FDA-related electronic records or signatures are involved, the applicability of Part 11 must be determined based on the specific record context and underlying requirements.
Which documents help to define the scope of validation effort?
Useful are tenant and module lists, process flowchart, sample order, recipe, alternative rules, inspection plan, role overview, and interface description. Supplement existing supplier documentation as well as known disruptions and modifications. This enables the functional area, IT, and partners to jointly identify critical handovers. A general estimation based solely on user count or product name does not adequately capture these differences.
Sources and review date
Source date: 6 October 2026. Public Haufe-X360 product pages, eWorkplace app catalog entry, roadmap, and developer documentation; no productive customer build or individual license scope confirmed. The 2026R1 roadmap announcement does not constitute a rollout validation. Regulatory reference: EU GMP for human medicinal products, Annex 11 and Chapter 4, both effective January 2011. FDA applicability to be determined separately. Figures and target deviations are internal work aids. Additional targeted source cross-check on 18 October 2026: Haufe process manufacturing page regarding material substitution without changes to base formulation.
- Haufe X360, cloud ERP and technology platform
- Haufe X360, process manufacturing
- eWorkplace Apps Quality Management Suite for Haufe X360
- Haufe X360, product roadmap
- Haufe X360 Developer Tool: Install Haufe X360 Application
- European Commission: EudraLex Volume 4
- EU GMP Annex 11: Computerised Systems
- EU GMP Chapter 4: Documentation
- FDA: Part 11 — Scope and Application
Sources checked: .
Clarify the transitions in your ERP-QMS integration
We support you in translating technical material decisions, existing supplier documentation, and your actual system combination into a clear and traceable testing and operational scope.
- Computer system validation →
Bring your GxP systems into validated operation, from laboratory software, MES and eQMS to ERP. We define the scope, plan risk-based tests using GAMP 5 and hand the evidence to QA for release.

